Cash and marketable securities held in trust account
263,398,723
261,298,144
258,955,961
256,650,172
Total assets
265,126,621
263,174,441
261,134,426
259,097,852
Accrued expenses
-
-
-
289,225
Accounts payable and accrued expenses
176,759
222,409
302,149
-
Accrued offering costs
-
75,000
75,000
75,000
Advances from related party
1,079
13,921
80,638
60,307
Promissory note related party
187
187
187
187
Total current liabilities
178,025
311,517
457,974
424,719
Deferred legal fees
3,249,148
3,023,074
2,517,919
2,401,554
Deferred underwriting fee payable
12,045,000
12,045,000
12,045,000
12,045,000
Total liabilities
15,472,173
15,379,591
15,020,893
14,871,273
Class a ordinary shares subject to possible redemption, 25,300,000 shares at a redemption value of 10.44 and 10.27 per share as of june 30, 2026 and december 31, 2025, respectively
264,171,907
261,838,786
259,780,731
257,263,958
Ordinary shares, value-Common Class A
74
74
74
74
Ordinary shares, value-Common Class B
844
844
844
844
Accumulated deficit
-14,518,377
-14,044,854
-13,668,116
-13,038,297
Total shareholders deficit
-14,517,459
-14,043,936
-13,667,198
-13,037,379
Total liabilities and shareholders deficit
265,126,621
263,174,441
261,134,426
259,097,852
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.